Anti generic strategy shouldn’t be underestimated. It’s like combining a patented and expired patent drug together to “improve compliance with taking prescribed medications”. Not ignoring also that the delivery system could potentially reduce side effects which with cancer patients would also reduce the cost effect of hospital stays etc for symptom management a huge economic savings and quality of life improvement. Potentially allowing people to continue everyday living whilst taking aggressive treatments. Don’t forget being sick is expensive in many different financial and non financial ways.
Anti generic strategy shouldn’t be underestimated. It’s like...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $62.84K | 565.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10428 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.0¢ |
Change
-0.005 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 11.5¢ | 11.0¢ | 167020 | ||
| Last updated 15.32pm 24/05/2024 ? | |||||
| SPL (ASX) Chart |